Bibliography
- Dai W , KlonerRA: Mesenchymal stem cell therapy for the injured heart. In: Rebuilding the Infarcted Heart. Wollert KC, Field LJ (Eds). Informa Healthcare London, UK 55–72 (2007).
- Müller-Ehmsen J , KrausgrillB, BurstVet al.: Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction.J. Mol. Cell. Cardiol.41(5) , 876–884 (2006).
- Zhang H , SongP, TangYet al.: Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution.J. Thorac. Cardiovasc. Surg.134(5) , 1234–1240 (2007).
- Hale SL , DaiW, DowJS, KlonerRA: Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: A quantitative assessment.Life Sci.83(13–14) , 511–515 (2008).
- Christman KL , VardanianAJ, FangQ, SieversRE, FokHH, LeeRJ: Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium.J. Am. Coll. Cardiol.44(3) , 654–660 (2004).
- Kofidis T , LeblDR, MartinezEC, HoytG, TanakaM, RobbinsRC: Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury.Circulation112(Suppl. 9) , I173–I177 (2005).
- Kutschka I , ChenIY, KofidisTet al.: Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts.Circulation114(Suppl. 1) , I167–I173 (2006).
- Dubois G , SegersVF, BellamyVet al.: Self-assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardium.J. Biomed. Mater. Res. B Appl. Biomater.87(1) , 222–228 (2008).
- Wang CC , ChenCH, LinWWet al.: Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction.Cardiovasc. Res.77(3) , 515–524 (2008).
- Leor J , AmsalemY, CohenS: Cells, scaffolds, and molecules for myocardial tissue engineering.Pharmacol. Ther.105(2) , 151–163 (2005).
- Christman KL , LeeRJ: Biomaterials for the treatment of myocardial infarction.J. Am. Coll. Cardiol.48(5) , 907–913 (2006).
- Dai W , HaleSL, MartinBJet al.: Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short and long-term effects.Circulation112(2) , 214–223 (2005).
- Dai W , WoldLE, DowJS, KlonerRA: Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: A novel approach to preserve cardiac function after myocardial infarction.J. Am. Coll. Cardiol.46(4) , 714–719 (2005).
- Rivière C , BoudghèneFP, GazeauFet al.: Iron oxide nanoparticle-labeled rat smooth muscle cells: cardiac MR imaging for cell graft monitoring and quantitation.Radiology235(3) , 959–967 (2005).
- Amsalem Y , MardorY, FeinbergMSet al.: Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium.Circulation116(Suppl. 11) , I38–I45 (2007).
- Terrovitis J , StuberM, YoussefAet al.: Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart.Circulation117(12) , 1555–1562 (2008).
- Freyman T , PolinG, OsmanHet al.: A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.Eur. Heart J.27(9) , 1114–1122 (2006).
- Hill JM , DickAJ, RamanVKet al.: Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells.Circulation108(8) , 1009–1014 (2003).
- Dow J , SimkhovichBZ, KedesL, KlonerRA: Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy.Cardiovasc. Res.67(2) , 301–307 (2005).